Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 47: 681-685, 2001;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (31)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sillanaukee, P.
Right arrow Articles by Olsson, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sillanaukee, P.
Right arrow Articles by Olsson, U.
Related Collections
Right arrow Proteomics and Protein Markers
Right arrow Drug Monitoring and Toxicology
(Clinical Chemistry. 2001;47:681-685.)
© 2001 American Association for Clinical Chemistry, Inc.

Articles

Improved Diagnostic Classification of Alcohol Abusers by Combining Carbohydrate-deficient Transferrin and {gamma}-Glutamyltransferase

Pekka Sillanaukee1,2,3,a and Ulf Olsson4

1 Pharmacia & Upjohn Diagnostics AB, Alcohol Related Diseases, 751 82 Uppsala, Sweden.

2 University of Tampere, Medical School and Tampere University Hospital, Department of Clinical Chemistry, 33014 Tampere, Finland.

3 Karolinska Institute, Medical School, 171 77 Stockholm, Sweden.

4 Swedish University of Agricultural Sciences, Department of Biometry and Informatics, 750 07 Uppsala, Sweden.
a Address correspondence to this author at: Oy Finnish Immunotechnology Ltd., Lenkkeilijänkatu 8, 33 520 Tampere, Finland. Fax 358-3-31387050; e-mail Pekka.Sillanaukee{at}finnish-immunotech.com.

Background: Biochemical markers can provide objective evidence of high alcohol consumption. However, currently available markers have limitations in their diagnostic performance.

Methods: The diagnostic values of the most frequently used markers [carbohydrate-deficient transferrin (CDT), {gamma}-glutamyltransferase (GGT), aspartate aminotransferase, alanine aminotransferase, and mean corpuscular volume] were studied in an analysis of six different clinical studies (n = 1412) on alcohol abusers and social drinkers. The purpose of the analyses was to determine whether a combination of markers would improve the diagnosis of subjects.

Results: Discrimination between alcohol abusers and social drinkers, as measured by the areas under nonparametric ROC plots, was significantly better (P <0.001) for the new combined marker [{gamma}-CDT = 0.8 · ln(GGT) + 1.3 · ln(CDT)] than for any of the separate markers or combination of CDT or GGT with other markers. The cutoff values for {gamma}-CDT (6.5) can be taken to be the same among males and females.

Conclusions: The combined variable {gamma}-CDT is a powerful tool to discriminate alcohol abusers from social drinkers and is recommended for clinical use.




The following articles in journals at HighWire Press have cited this article:


Home page
 Alcohol AlcoholHome page
S. H. STEWART, G. J. CONNORS, and A. HUTSON
ETHNICITY AND GAMMA-GLUTAMYLTRANSFERASE IN MEN AND WOMEN WITH ALCOHOL USE DISORDERS
Alcohol Alcohol., January 1, 2007; 42(1): 24 - 27.
[Abstract] [Full Text] [PDF]

Home page
 Alcohol AlcoholHome page
J. HIETALA, H. KOIVISTO, P. ANTTILA, and O. NIEMELA
COMPARISON OF THE COMBINED MARKER GGT-CDT AND THE CONVENTIONAL LABORATORY MARKERS OF ALCOHOL ABUSE IN HEAVY DRINKERS, MODERATE DRINKERS AND ABSTAINERS
Alcohol Alcohol., September 1, 2006; 41(5): 528 - 533.
[Abstract] [Full Text] [PDF]

Home page
 Alcohol AlcoholHome page
S. ARADOTTIR, G. ASANOVSKA, S. GJERSS, P. HANSSON, and C. ALLING
PHOSPHATIDYLETHANOL (PEth) CONCENTRATIONS IN BLOOD ARE CORRELATED TO REPORTED ALCOHOL INTAKE IN ALCOHOL-DEPENDENT PATIENTS
Alcohol Alcohol., July 1, 2006; 41(4): 431 - 437.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
B. Lumbreras-Lacarra, J. M. Ramos-Rincon, and I. Hernandez-Aguado
Methodology in Diagnostic Laboratory Test Research in Clinical Chemistry and Clinical Chemistry and Laboratory Medicine
Clin. Chem., March 1, 2004; 50(3): 530 - 536.
[Abstract] [Full Text] [PDF]

Home page
 Alcohol AlcoholHome page
J. Chen, K. M. Conigrave, P. Macaskill, J. B. Whitfield, and L. Irwig
COMBINING CARBOHYDRATE-DEFICIENT TRANSFERRIN AND GAMMA-GLUTAMYLTRANSFERASE TO INCREASE DIAGNOSTIC ACCURACY FOR PROBLEM DRINKING
Alcohol Alcohol., November 1, 2003; 38(6): 574 - 582.
[Abstract] [Full Text] [PDF]

Home page
 Alcohol AlcoholHome page
M. J. Schwarz, I. Domke, A. Helander, P. M. W. Janssens, J. van Pelt, B. Springer, M. Ackenheil, K. Bernhardt, G. Weigl, and M. Soyka
MULTICENTRE EVALUATION OF A NEW ASSAY FOR DETERMINATION OF CARBOHYDRATE-DEFICIENT TRANSFERRIN
Alcohol Alcohol., May 1, 2003; 38(3): 270 - 275.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
F. J. Legros, V. Nuyens, M. Baudoux, K. Zouaoui Boudjeltia, J.-L. Ruelle, J. Colicis, F. Cantraine, and J.-P. Henry
Use of Capillary Zone Electrophoresis for Differentiating Excessive from Moderate Alcohol Consumption
Clin. Chem., March 1, 2003; 49(3): 440 - 449.
[Abstract] [Full Text] [PDF]

Home page
 Alcohol AlcoholHome page
P. Sillanaukee, N. Strid, P. Jousilahti, E. Vartiainen, K. Poikolainen, S. Nikkari, J. P. Allen, and H. Alho
Association of self-reported diseases and health care use with commonly used laboratory markers for alcohol consumption
Alcohol Alcohol., July 1, 2001; 36(4): 339 - 345.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the American Association for Clinical Chemistry.